Survival and Prognostic Factors in Patients with Brain Metastases from Malignant Melanoma

Publisher： Karger

E-ISSN： 2296-5262|27|2|145-149

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.27, Iss.2, 2004-05, pp. : 145-149

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Prognostic Factors for Patients with Microsurgically Resected Brain Metastases

By  

Oncology Research and Treatment, Vol. 25, Iss. 5, 2002-11 ,pp. : 420-425

Karger

Access to resources Recommend Favorite

Clinicopathological characteristics of cutaneous malignant melanoma in patients at a tertiary hospital in Macaronesia. Survival as a function of locoregional prognostic factors per the American Joint Committee on Cancer

By  

INTERNATIONAL JOURNAL OF DERMATOLOGY, Vol. 57, Iss. 2, 2018-02 ,pp. : 193-201

John Wiley & Sons Inc

Access to resources Recommend Favorite

Prognostic Factors in Metastatic Malignant Melanoma

By  

Oncology, Vol. 55, Iss. 1, 1997-12 ,pp. : 59-64

Karger

Access to resources Recommend Favorite

Peritumoral D2‐40 Chalkley score independently predicts metastases and survival in patients with cutaneous malignant melanoma

By  

JOURNAL OF CUTANEOUS PATHOLOGY, Vol. 42, Iss. 10, 2015-10 ,pp. : 699-711

John Wiley & Sons Inc

Access to resources Recommend Favorite

Improved survival of patients with melanoma brain metastases in the era of targeted BRAF and immune checkpoint therapies

By  

CANCER, Vol. 124, Iss. 2, 2018-01 ,pp. : 297-305

John Wiley & Sons Inc

Access to resources Recommend Favorite